Übersichtsarbeit
Anti-leishmanial Drug Discovery: Rising to the Challenges of a Highly Neglected Disease
Molecular Interventions · 2010
DOI: 10.1124/mi.10.2.4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Interventions, 2010. Verfasst von Elizabeth R Sharlow und 3 weiteren Autor:innen. Beteiligte Einrichtung: Drug Discovery Institute, University of Pittsburgh, Pittsburgh, PA 15260, USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
AnimalsAntiprotozoal AgentsDrug DiscoveryFemaleHumansLeishmaniaLeishmaniasis
Substanzen
Antiprotozoal Agents
Autor:innen und Institutionen
- Drug Discovery Institute, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Zitieren
APA
Sharlow, E. R., Grögl, M., Johnson, J., & Lazo, J. S. (2010). Anti-leishmanial Drug Discovery: Rising to the Challenges of a Highly Neglected Disease. Molecular Interventions. https://doi.org/10.1124/mi.10.2.4
Vancouver
Sharlow ER, Grögl M, Johnson J, Lazo JS. Anti-leishmanial Drug Discovery: Rising to the Challenges of a Highly Neglected Disease. Molecular Interventions. 2010. doi:10.1124/mi.10.2.4
BibTeX
@article{Sharlow2010,
author = {Sharlow, Elizabeth R and Grögl, Max and Johnson, Jacob and Lazo, John S},
title = {Anti-leishmanial Drug Discovery: Rising to the Challenges of a Highly Neglected Disease},
journal = {Molecular Interventions},
year = {2010},
doi = {10.1124/mi.10.2.4}
}
EUVIMED